Skip to content
10-Q

Quarterly Report

NEOGENIX ONCOLOGY INC

0001144204-12-023245

← back to feed
Filed
Apr 23, 2012 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2011 · Mar 31, 2012 22.92M sh
Stock Repurchased Q3 2011 · Sep 30, 2011 $195.75K
Capex Q3 2011 · Sep 30, 2011 $55.98K
Capex Q3 2011 · Sep 30, 2011 $1.68M
Capex Q3 2011 · Sep 30, 2010 $375.86K
Operating Cash Flow Q3 2011 · Sep 30, 2011 −$6.12M
Operating Cash Flow Q3 2011 · Sep 30, 2011 −$43.82M
Operating Cash Flow Q3 2011 · Sep 30, 2010 −$10.83M
Cash And Equivalents Q3 2011 · Sep 30, 2011 $5.9M
Cash And Equivalents Q3 2011 · Dec 31, 2010 $3.22M
Cash And Equivalents Q3 2011 · Sep 30, 2010 $1.75M
Cash And Equivalents Q3 2011 · Dec 31, 2009 $6.66M
Stockholders Equity Q3 2011 · Sep 30, 2011 $6.47M
Stockholders Equity Q3 2011 · Dec 31, 2010 $11.32M
Current Liabilities Q3 2011 · Sep 30, 2011 $1.89M
Current Liabilities Q3 2011 · Dec 31, 2010 $1.5M
Total Liabilities Q3 2011 · Sep 30, 2011 $2.95M
Total Liabilities Q3 2011 · Dec 31, 2010 $1.58M
Current Assets Q3 2011 · Sep 30, 2011 $6.29M
Current Assets Q3 2011 · Dec 31, 2010 $4.32M
Total Assets Q3 2011 · Sep 30, 2011 $9.42M
Total Assets Q3 2011 · Dec 31, 2010 $12.9M
Sga Expense Q3 2011 · Sep 30, 2011 $2.07M
Sga Expense Q3 2011 · Sep 30, 2011 $10.42M
Sga Expense Q3 2011 · Sep 30, 2011 $74.87M
Sga Expense Q3 2011 · Sep 30, 2010 $2.69M
Sga Expense Q3 2011 · Sep 30, 2010 $9.78M
Rd Expense Q3 2011 · Sep 30, 2011 $1.22M
Rd Expense Q3 2011 · Sep 30, 2011 $5.89M
Rd Expense Q3 2011 · Sep 30, 2011 $38.72M
Rd Expense Q3 2011 · Sep 30, 2010 $1.96M
Rd Expense Q3 2011 · Sep 30, 2010 $6.34M
Net Income Q3 2011 · Sep 30, 2011 −$3.23M
Net Income Q3 2011 · Sep 30, 2011 −$15.64M
Net Income Q3 2011 · Sep 30, 2011 −$112.07M
Net Income Q3 2011 · Sep 30, 2010 −$4.58M
Net Income Q3 2011 · Sep 30, 2010 −$15.92M
Operating Income Q3 2011 · Sep 30, 2011 −$3.29M
Operating Income Q3 2011 · Sep 30, 2011 −$16.31M
Operating Income Q3 2011 · Sep 30, 2011 −$113.59M
Operating Income Q3 2011 · Sep 30, 2010 −$4.65M
Operating Income Q3 2011 · Sep 30, 2010 −$16.12M